Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients. - Wikidata - wikimedia - TriplyDB

Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.

Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.

http://www.wikidata.org/entity/Q33395782

about

Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.Ten-year screening for thrombocytopenia after aortic valve replacement.Hematological disorders: a commonly unrecognized cause of acute stroke.

P2860

Q33410242-326433C5-2CA5-480B-B50F-B30E28295CEE Q33413153-7BAA55D8-E343-4B7A-9AFC-722E4569E4F4 Q38883180-3FC16507-B39A-4379-A5A2-01AB9A7CC508

P2860

Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.

http://www.wikidata.org/entity/Q33395782

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@ast

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@en

type

label

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@ast

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@en

prefLabel

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@ast

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@en

P1433

Q33395782-3A8FD14E-DD97-4526-BD31-D6E190503290

P1476

Q33395782-031115F0-33E1-449F-9FAF-ECEB35A6E9A4

P2093

Q33395782-0C4C24C3-0F32-46EF-8835-D71BFCCB3288

Q33395782-2AF84853-8043-487B-B77B-B89365C128B2

Q33395782-55FCE055-95E3-49EE-862D-801D153AD5C9

Q33395782-579DE5DF-408D-415C-8566-B4C71E8A3E19

Q33395782-69A723F9-B687-4056-A7D2-02B33DC975BD

Q33395782-7176BB57-8086-47C3-BADA-6ADD7945C356

Q33395782-778E5244-4E3E-4D02-9A10-48981B7D82C6

Q33395782-87CBBB77-5E34-4541-BF69-E26C39AEC938

Q33395782-8F3BD754-9BE0-4D0D-B902-039E5D67ADF6

Q33395782-BD392ADE-E980-486E-84F7-A3721B0DAE78

P2860

Q33395782-071D8DD1-EC4E-40CC-89CC-65E5197EC44C

Q33395782-0D2FB115-3177-4B17-83AB-59B67726B032

Q33395782-0D70E6A9-6EE3-4799-9DF7-2B537106897F

Q33395782-17B5DBCF-3F4D-4B89-A8D5-F3B5C8479F9B

Q33395782-2605DAB7-73F2-470C-9319-0220C8A68601

Q33395782-3E3AB3BF-5DF3-4091-9B70-1BD90A2C0640

Q33395782-40B1E512-7D6D-4A07-A611-65EEC7C56FC6

Q33395782-4B685C27-7D34-401E-9F2F-76A4C495FD3F

Q33395782-8066D85B-6576-45F4-91FE-A1B5A6EFDBE8

Q33395782-85929522-910C-447E-961F-E8EE655020C7

P304

Q33395782-E32CAF82-17BB-4810-9874-4272085E03CE

P31

Q33395782-6A26986C-778E-482A-A837-6BD3EDF1AD62

P356

Q33395782-3AE63B9A-7AD6-4034-B6D5-5064D6008100

P407

Q33395782-FF5BF6B7-47DE-49D9-BC05-E918AAD2AA82

P433

Q33395782-F336BB11-A1C7-4B4E-85DE-A44BA8C2F519

P478

Q33395782-A91CA3A3-9494-4177-BD19-8CFB9AE76531

P50

Q33395782-05ADFADC-0EF3-4397-A8DB-12F5490632D9

P577

Q33395782-36AFD541-1283-43EC-AAA1-7C282E8BA213

P5875

Q33395782-1A254958-2285-482F-96C2-E352B4326BF3

P698

Q33395782-475B3154-1FAC-4E0F-9A02-74841C52CF4F

P921

Q33395782-4255E210-1166-4C87-9BFB-2DFA42C1AC14

Q33395782-C2402EE6-5232-4712-B336-7DABCFEAEC17

P932

Q33395782-94664188-44C2-4E52-A59F-BA08B7FC19FE

P356

J.1365-2141.2011.08775.X

P1433

British Journal of Haematology

P1476

Prospective multicentre cohort ...... ute ischaemic stroke patients.

@en

P2093

Akiko Kada

http://www.w3.org/2001/XMLSchema#string

Haruko Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hiroaki Naritomi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kawano

http://www.w3.org/2001/XMLSchema#string

Isami Kakutani

http://www.w3.org/2001/XMLSchema#string

Jo-Ann I Sheppard

http://www.w3.org/2001/XMLSchema#string

Kazunori Toyoda

http://www.w3.org/2001/XMLSchema#string

Kazuo Minematsu

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Nagatsuka

http://www.w3.org/2001/XMLSchema#string

Makoto Uchino

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Guidelines for the Early Management of Adults With Ischemic Stroke

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Temporal aspects of heparin-induced thrombocytopenia.

Laboratory diagnosis of immune heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin.

Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia Type II in subarachnoid hemorrhage patients: incidence and complications.

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?

P304

378-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2011.08775.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P50

Theodore E Warkentin

P577

2011-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51217943

http://www.w3.org/2001/XMLSchema#string

P698

21671895

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

multicenter trial

P932

3170484

http://www.w3.org/2001/XMLSchema#string